by Vandana Singh | Apr 22, 2026 | General
The U.S. Food and Drug Administration (FDA) on Wednesday delayed its decision on Sanofi SA’s (NASDAQ:SNY) subcutaneous Sarclisa formulation while separately broadening the eligible patient population for Tzield. FDA Extends Sarclisa SC Review Timeline The FDA has...
by Akanksha Bakshi | Apr 22, 2026 | General
Accenture plc (NYSE:ACN) shares are trading lower during Wednesday’s premarket session as the stock underperforms a risk-on tape where tech is leading early, down 0.21%. Nasdaq futures are up 0.69% while S&P 500 futures have gained 0.54%, and Technology (XLK) is...
by Khyathi Dalal | Apr 22, 2026 | General
Bitcoin climbed back above $78,000 after President Trump extended the Iran ceasefire. Liquidations stand at $246.08 million over the past 24 hours while Bitcoin ETFs saw $11.8 million in net inflows on Tuesday, while Ethereum ETFs reported $43.4 million in net...
by Nabaparna Bhattacharya | Apr 22, 2026 | General
Amneal Pharmaceuticals (NASDAQ:AMRX) shares are up during Wednesday’s premarket session as the company has entered into a definitive agreement to acquire Kashiv BioSciences. Acquisition Details Amenal stock is up 3.76%, as the acquisition aims to create a global...
by Avi Kapoor | Apr 22, 2026 | General
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst...
Recent Comments